Lv2
198 积分 2024-01-24 加入
DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer
15小时前
已完结
The Iroquois family of genes: from body building to neural patterning
1天前
求助中
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
2个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
2个月前
已完结
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial
2个月前
已完结
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy
2个月前
已完结
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
2个月前
已完结
Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer
2个月前
已关闭
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
2个月前
已完结
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
